Analyst Ranking
Bottom 3%
#4942 out of 5064 analysts
Average Return
-18.13%
Win Rate
33%9 out of 27
Risk vs Reward
Poor
Good

John Sourbeer's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cryoport IncCYRX
+64.37%$6.09$10.01
2025-04-01 -
2025-10-15
Strong Buy
Cryoport IncCYRX
+40.99%$7.10$10.01
2025-03-24 -
2025-10-15
Strong Buy
Catalent IncCTLT
+33.32%$43.85$58.46
2023-06-13 -
2024-02-06
Strong Buy
Catalent IncCTLT
+19.35%$48.98$58.46
2023-08-30 -
2024-02-06
Strong Buy
Icon PLCICLR
+18.89%$215.91$256.69
2022-09-07 -
2023-09-06
Strong Buy

John Sourbeer Analyst Color

Get additional color on John Sourbeer's coverage of popular stocks

John Sourbeer's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Qiagen NvQGEN
5Hold$50.00+5.24%Maintains
2 months ago
West Pharmaceutical Services IncWST
4Strong Buy$320.00+21.70%Maintains
3 months ago
Icon PLCICLR
2Strong Buy$240.00+27.76%Maintains
3 months ago
Cryoport IncCYRX
6Strong Buy$11.00+9.89%Maintains
6 months ago
Stevanato Group SpaSTVN
2Hold$23.50-1.80%Maintains
7 months ago
Quidelortho CorpQDEL
4Hold$45.00+64.77%Maintains
8 months ago
Pacific Biosciences Of California IncPACB
3Hold$2.00+14.94%Downgrades
a year ago
Illumina IncILMN
3Hold$145.00+55.91%Maintains
a year ago
Singular Genomics Systems IncOMIC
2Hold$15.00N/AMaintains
2 years ago
Medpace Holdings IncMEDP
4Strong Buy$480.00N/AMaintains
2 years ago
Akoya Biosciences IncAKYA
2Strong Buy$7.50N/AMaintains
2 years ago
Bruker CorpBRKR
3Strong Buy$102.00N/AMaintains
2 years ago
Catalent IncCTLT
4Hold$63.50N/ADowngrades
2 years ago
Nanostring Technologies IncNSTGQ
2Strong Buy$2.50N/AMaintains
2 years ago
10x Genomics IncTXG
1Hold$50.00N/AInitiates Coverage On
3 years ago
Syneos Health IncSYNH
1Hold$68.00N/AInitiates Coverage On
3 years ago
Abbott LaboratoriesABT
2Strong Buy$128.00N/AMaintains
3 years ago
Zymergen IncZY
2Hold$4.00N/AMaintains
4 years ago
Ortho Clinical Diagnostics Holdings PLCOCDX
1Strong Buy$23.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.